How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved - The New York Times

Linking pages

Pro-pharma Democrats kill bill to lower drug costs — advocates ask: “What did they get for that?” | Salon.com https://www.salon.com/2021/10/29/pro-pharma-democrats-bill-to-lower-costs--advocates-ask-what-did-they-get-for-that/?user_id=%2A%7CEMAIL%7C%2A 419 comments
That $56,000 Drug? Blame Medicare. - The New York Times https://www.nytimes.com/2021/08/20/business/drug-cost-medicare-alzheimers.html 124 comments
Alzheimer’s Drug May Benefit Some Patients, New Data Shows - The New York Times https://www.nytimes.com/2022/11/29/health/lecanemab-alzheimers-drug.html 83 comments
Critical elements of leading Alzheimer’s study possibly fraudulent | Alzheimer's | The Guardian https://theguardian.com/society/2022/jul/23/alzheimers-study-fraudulent 17 comments
Alzheimer's drug Aduhelm: What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' | CNN Politics https://www.cnn.com/2021/09/26/politics/alzheimers-drug-aduhelm-fda-approval/index.html 5 comments
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacks - The New York Times https://www.nytimes.com/2022/09/26/business/biogen-900-million-lawsuit-kickbacks.html 3 comments
House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval - The New York Times https://www.nytimes.com/2021/09/02/health/aduhelm-fda.html 3 comments
In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug - The New York Times https://www.nytimes.com/2021/07/08/health/aduhelm-alzheimers-fda.html 1 comment
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm - The New York Times https://www.nytimes.com/2024/01/31/business/biogen-alzheimers-aduhelm.html 1 comment

Linking pages

Linked pages